Lau Darren, Ogbogu Ubaka, Taylor Benjamin, Stafinski Tania, Menon Devidas, Caulfield Timothy
Cell Stem Cell. 2008 Dec 4;3(6):591-4. doi: 10.1016/j.stem.2008.11.001.
Despite the immature state of stem cell medicine, patients are seeking and accessing putative stem cell therapies in an "early market" in which direct-to-consumer advertising via the internet likely plays an important role. We analyzed stem cell clinic websites and appraised the relevant published clinical evidence of stem cell therapies to address three questions about the direct-to-consumer portrayal of stem cell medicine in this early market: What sorts of therapies are being offered? How are they portrayed? Is there clinical evidence to support the use of these therapies? We found that the portrayal of stem cell medicine on provider websites is optimistic and unsubstantiated by peer-reviewed literature.
尽管干细胞医学尚不成熟,但患者正在一个“早期市场”中寻求并接受所谓的干细胞疗法,在这个市场中,通过互联网进行的直接面向消费者的广告可能起到了重要作用。我们分析了干细胞诊所网站,并评估了干细胞疗法的相关已发表临床证据,以解决关于这个早期市场中干细胞医学直接面向消费者的描述的三个问题:提供了哪些类型的疗法?它们是如何被描述的?是否有临床证据支持这些疗法的使用?我们发现,提供者网站上对干细胞医学的描述很乐观,且没有经过同行评审的文献证实。